"Designing Growth Strategies is in our DNA"

U.S. Drug Delivery Systems Market Size, Share & Industry Analysis, By Type (Inhalation, Transdermal, Injectable, and Others), By Device Type (Conventional and Advanced), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), and Country Forecast, 2024-2032

Last Updated: December 01, 2025 | Format: PDF | Report ID: FBI107910

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. New Product Launches, Key Players
    2. Technological Advancements in the Drug Device Systems Market
    3. Key Industry Developments - Mergers, Acquisitions, and Partnerships
    4. Impact of COVID-19 on the Market
  5. U.S. Drug Delivery Systems Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Inhalation
      2. Transdermal
      3. Injectable
      4. Others
    2. Market Analysis, Insights and Forecast – By Device Type
      1. Conventional
      2. Advanced
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Others
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2023)
    2. Company Profiles (Overview, Services, SWOT Analysis, Recent Developments, Strategies, financials (Based on Availability))
      1. BD
        1. Overview,
        2. Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      2. Baxter
        1. Overview,
        2. Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      3. Medtronic
        1. Overview,
        2. Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      4. Hikma Pharmaceuticals PLC
        1. Overview,
        2. Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      5. Teva Pharmaceuticals USA, Inc.
        1. Overview,
        2. Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      6. Teikoku Pharma USA, Inc.
        1. Overview,
        2. Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      7. sanofi-aventis U.S. LLC
        1. Overview,
        2. Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      8. Other Prominent Players
        1. Overview,
        2. Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. New Product Launches, Key Players
    2. Technological Advancements in the Drug Device Systems Market
    3. Key Industry Developments - Mergers, Acquisitions, and Partnerships
    4. Impact of COVID-19 on the Market
  5. U.S. Drug Delivery Systems Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Inhalation
      2. Transdermal
      3. Injectable
      4. Others
    2. Market Analysis, Insights and Forecast – By Device Type
      1. Conventional
      2. Advanced
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Others
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2023)
    2. Company Profiles (Overview, Services, SWOT Analysis, Recent Developments, Strategies, financials (Based on Availability))
      1. BD
        1. Overview,
        2. Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      2. Baxter
        1. Overview,
        2. Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      3. Medtronic
        1. Overview,
        2. Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      4. Hikma Pharmaceuticals PLC
        1. Overview,
        2. Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      5. Teva Pharmaceuticals USA, Inc.
        1. Overview,
        2. Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      6. Teikoku Pharma USA, Inc.
        1. Overview,
        2. Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      7. sanofi-aventis U.S. LLC
        1. Overview,
        2. Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      8. Other Prominent Players
        1. Overview,
        2. Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
Read Less

Figure 1:  U.S. Drug Delivery Systems Market Revenue Breakdown (USD Million, %), By Type, 2023 & 2032

Figure 2:  U.S. Drug Delivery Systems Market Value Share (%), by Type, 2023 & 2032

Figure 3:  U.S. Drug Delivery Systems Market Value Share (%), by Device Type, 2023 & 2032

Figure 4:  U.S. Drug Delivery Systems Market Value Share (%), by Distribution Channel, 2023 & 2032

Figure 5:  U.S. Drug Delivery Systems Market Share (%), By Company, 2023

Table 1:  U.S. Drug Delivery Systems Market Revenue (USD billion) Forecast, by Type, 2019–2032

Table 2:  U.S. Drug Delivery Systems Market Revenue (USD billion) Forecast, by Device Type, 2019–2032

Table 3:  U.S. Drug Delivery Systems Market Revenue (USD billion) Forecast, by Distribution Channel, 2019–2032

U.S. Drug Delivery Systems Market
  • 2019-2032
  • 2023
  • 2019-2022
  • 70
Download Free Sample

    man icon
    Mail icon
    Captcha refresh
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports